Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Derom
Indacaterol, a Novel Inhaled 2-Agonist, Provides Sustained 24-H Bronchodilation in Asthma
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Related publications
Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD
Thorax
Pulmonary
Respiratory Medicine
Asthma Medication in Finnish Olympic Athletes: No Signs of Inhaled ??2-Agonist Overuse
Medicine and Science in Sports and Exercise
Sports Medicine
Physical Therapy
Sports Science
Orthopedics
Sports Therapy
Rehabilitation
Comparison of Vilanterol, a Novel Long-Acting Beta2 Agonist, With Placebo and a Salmeterol Reference Arm in Asthma Uncontrolled by Inhaled Corticosteroids
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
A Novel Form of Receptor Interaction May Contribute to -Agonist Resistance in Asthma
Thorax
Pulmonary
Respiratory Medicine
Inhaled Ciclesonide Versus Inhaled Budesonide or Inhaled Beclomethasone or Inhaled Fluticasone for Chronic Asthma in Adults: A Systematic Review
BMC Family Practice
Family Practice
PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Inhaled Corticosteroid Dose Response in Asthma
Annals of Allergy, Asthma and Immunology
Respiratory Medicine
Pulmonary
Allergy
Immunology
Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma
Respiratory Medicine
Pulmonary
Respiratory Medicine
Inhaled Sodium Cromoglycate in Children With Asthma
Thorax
Pulmonary
Respiratory Medicine
